Promoter variant rs2301228 on the neural cell adhesion molecule 1 gene confers risk of schizophrenia in Han Chinese

Schizophrenia Research

Volumn 160, Issue 1-3, 2014, Pages 88-96

  Zhang, Wen ^a   Xiao, Mei Sheng ^a   Ji, Shuang ^a   Tang, Jinsong ^b   Xu, Ling ^a,c   Li, Xiao ^a,c   Li, Ming ^d   Wang, Hui Zhen ^a,e   Jiang, Hong Yan ^f   Zhang, Deng Feng ^a,c   Wang, Jicai ^f   Zhang, Shuliang ^g   Xu, Xiu Feng ^f   Yu, Li ^h   Zheng, Ping ^a   Chen, Xiaogang ^b   Yao, Yong Gang ^a  

^a KUNMING INSTITUTE OF ZOOLOGY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

^c UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^d JOHNS HOPKINS UNIVERSITY   (United States)

^e UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

^f KUNMING MEDICAL UNIVERSITY   (China)

^g The First Affiliated Hospital of Kunming Medical University ^*  (China)

^h YUNNAN UNIVERSITY   (China)

Author keywords

Association; ELISA; Luciferase assay; NCAM1; Replication; Schizophrenia

Indexed keywords

NERVE CELL ADHESION MOLECULE; NERVE CELL ADHESION MOLECULE 1; UNCLASSIFIED DRUG; CD56 ANTIGEN; MESSENGER RNA; NCAM1 PROTEIN, HUMAN;

ADOLESCENT; ANIMAL CELL; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENE REPLICATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC REGULATION; GENETIC RISK; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; GENOTYPE; HAN CHINESE; HAPLOTYPE; HUMAN; LUCIFERASE ASSAY; MAJOR CLINICAL STUDY; MALE; NCAM1 GENE; NERVE CELL DIFFERENTIATION; NEURAL STEM CELL; NONHUMAN; NUCLEOTIDE BINDING SITE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RHESUS MONKEY; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; ADULT; ANIMAL; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD; CELL CULTURE; CHINA; GENETIC PREDISPOSITION; GENETICS; METABOLISM; NERVOUS SYSTEM DEVELOPMENT; PHYSIOLOGY;

ADULT; ANIMALS; ANTIGENS, CD56; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CELLS, CULTURED; CHINA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; MACACA MULATTA; MALE; NEURAL CELL ADHESION MOLECULES; NEURAL STEM CELLS; NEUROGENESIS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; RNA, MESSENGER; SCHIZOPHRENIA;

EID: 84928209498     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2014.09.036     Document Type: Article

References (52)

1. Albrecht A., Stork O. Are NCAM deficient mice an animal model for schizophrenia?. Front. Behav. Neurosci. 2012, 6:43.
2. Albrecht A., Bergado-Acosta J.R., Pape H.C., Stork O. Role of the neural cell adhesion molecule (NCAM) in amygdalo-hippocampal interactions and salience determination of contextual fear memory. Int. J. Neuropsychopharmacol. 2010, 13(5):661-674.
3. Angata K., Long J.M., Bukalo O., Lee W., Dityatev A., Wynshaw-Boris A., Schachner M., Fukuda M., Marth J.D. Sialyltransferase ST8Sia-II assembles a subset of polysialic acid that directs hippocampal axonal targeting and promotes fear behavior. J. Biol. Chem. 2004, 279(31):32603-32613.
4. Arai M., Itokawa M., Yamada K., Toyota T., Arai M., Haga S., Ujike H., Sora I., Ikeda K., Yoshikawa T. Association of neural cell adhesion molecule 1 gene polymorphisms with bipolar affective disorder in Japanese individuals. Biol. Psychiatry 2004, 55(8):804-810.
5. Arnett D.K., Meyers K.J., Devereux R.B., Tiwari H.K., Gu C.C., Vaughan L.K., Perry R.T., Patki A., Claas S.A., Sun Y.V., Broeckel U., Kardia S.L. Genetic variation in NCAM1 contributes to left ventricular wall thickness in hypertensive families. Circ. Res. 2011, 108(3):279-283.
6. Atz M.E., Rollins B., Vawter M.P. NCAM1 association study of bipolar disorder and schizophrenia: polymorphisms and alternatively spliced isoforms lead to similarities and differences. Psychiatr. Genet. 2007, 17(2):55-67.
7. Barbeau D., Liang J.J., Robitalille Y., Quirion R., Srivastava L.K. Decreased expression of the embryonic form of the neural cell adhesion molecule in schizophrenic brains. Proc. Natl. Acad. Sci. U. S. A. 1995, 92(7):2785-2789.
8. Barrett J.C., Fry B., Maller J., Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21(2):263-265.
9. Barton C.H., Mann D.A., Walsh F.S. Characterization of the human N-CAM promoter. Biochem. J. 1990, 268(1):161-168.
10. Bi R., Zhao L., Zhang C., Lu W., Feng J.-Q., Wang Y., Ni J., Zhang J., Li G.-D., Hu Q.-X., Wang D., Yao Y.-G., Li T. No association of the LRRK2 genetic variants with Alzheimer's disease in Han Chinese individuals. Neurobiol. Aging 2014, 35(2). 444.e5-9.
11. Brennaman L.H., Maness P.F. NCAM in neuropsychiatric and neurodegenerative disorders. Adv. Exp. Med. Biol. 2010, 663:299-317.
12. Brennand K.J., Simone A., Jou J., Gelboin-Burkhart C., Tran N., Sangar S., Li Y., Mu Y., Chen G., Yu D., McCarthy S., Sebat J., Gage F.H. Modelling schizophrenia using human induced pluripotent stem cells. Nature 2011, 473(7346):221-225.
13. Colantuoni C., Lipska B.K., Ye T., Hyde T.M., Tao R., Leek J.T., Colantuoni E.A., Elkahloun A.G., Herman M.M., Weinberger D.R., Kleinman J.E. Temporal dynamics and genetic control of transcription in the human prefrontal cortex. Nature 2011, 478(7370):519-523.
14. Cox E.T., Brennaman L.H., Gable K.L., Hamer R.M., Glantz L.A., Lamantia A.S., Lieberman J.A., Gilmore J.H., Maness P.F., Jarskog L.F. Developmental regulation of neural cell adhesion molecule in human prefrontal cortex. Neuroscience 2009, 162(1):96-105.
15. Cremer H., Lange R., Christoph A., Plomann M., Vopper G., Roes J., Brown R., Baldwin S., Kraemer P., Scheff S., Barthels D., Rajewsky K., Wille W. Inactivation of the N-CAM gene in mice results in size reduction of the olfactory bulb and deficits in spatial learning. Nature 1994, 367(6462):455-459.
16. Deak K.L., Boyles A.L., Etchevers H.C., Melvin E.C., Siegel D.G., Graham F.L., Slifer S.H., Enterline D.S., George T.M., Vekemans M., McClay D., Bassuk A.G., Kessler J.A., Linney E., Gilbert J.R., Speer M.C. SNPs in the neural cell adhesion molecule 1 gene (NCAM1) may be associated with human neural tube defects. Hum. Genet. 2005, 117(2-3):133-142.
17. Eckhardt M., Bukalo O., Chazal G., Wang L., Goridis C., Schachner M., Gerardy-Schahn R., Cremer H., Dityatev A. Mice deficient in the polysialyltransferase ST8SiaIV/PST-1 allow discrimination of the roles of neural cell adhesion molecule protein and polysialic acid in neural development and synaptic plasticity. J. Neurosci. 2000, 20(14):5234-5244.
18. Farré D., Roset R., Huerta M., Adsuara J.E., Roselló L., Albà M.M., Messeguer X. Identification of patterns in biological sequences at the ALGGEN server: PROMO and MALGEN. Nucleic Acids Res. 2003, 31(13):3651-3653.
19. Furney S.J., Simmons A., Breen G., Pedroso I., Lunnon K., Proitsi P., Hodges A., Powell J., Wahlund L.O., Kloszewska I., Mecocci P., Soininen H., Tsolaki M., Vellas B., Spenger C., Lathrop M., Shen L., Kim S., Saykin A.J., Weiner M.W., Lovestone S. Genome-wide association with MRI atrophy measures as a quantitative trait locus for Alzheimer's disease. Mol. Psychiatry 2011, 16(11):1130-1138.
20. Gauderman W.J. Sample size requirements for matched case-control studies of gene-environment interaction. Stat. Med. 2002, 21(1):35-50.
21. Giegling I., Chiesa A., Mandelli L., Gibiino S., Hartmann A.M., Möller H.J., Schneider B., Schnabel A., Maurer K., De Ronchi D., Rujescu D., Serretti A. Influence of neuronal cell adhesion molecule (NCAM1) variants on suicidal behaviour and correlated traits. Psychiatry Res. 2010, 179(2):222-225.
22. Giegling I., Calati R., Porcelli S., Hartmann A.M., Möller H.J., De Ronchi D., Rujescu D., Serretti A. NCAM1, TACR1 and NOS genes and temperament: a study on suicide attempters and controls. Neuropsychobiology 2011, 64(1):32-37.
23. Hildebrandt H., Mühlenhoff M., Weinhold B., Gerardy-Schahn R. Dissecting polysialic acid and NCAM functions in brain development. J. Neurochem. 2007, 103(Suppl. 1):56-64.
24. Hildebrandt H., Mühlenhoff M., Oltmann-Norden I., Röckle I., Burkhardt H., Weinhold B., Gerardy-Schahn R. Imbalance of neural cell adhesion molecule and polysialyltransferase alleles causes defective brain connectivity. Brain 2009, 132(Pt 10):2831-2838.
25. Hirsch M.R., Valarche I., Deagostini-Bazin H., Pernelle C., Joliot A., Goridis C. An upstream regulatory element of the NCAM promoter contains a binding site for homeodomains. FEBS Lett. 1991, 287(1-2):197-202.
26. Holland M.M., Parson W. GeneMarker® HID: a reliable software tool for the analysis of forensic STR data. J. Forensic Sci. 2011, 56(1):29-35.
27. Jablensky A. The 100-year epidemiology of schizophrenia. Schizophr. Res. 1997, 28(2-3):111-125.
28. Jorgensen O.S., Bock E. Brain specific synaptosomal membrane proteins demonstrated by crossed immunoelectrophoresis. J. Neurochem. 1974, 23(4):879-880.
29. Kang H.J., Kawasawa Y.I., Cheng F., Zhu Y., Xu X., Li M., Sousa A.M., Pletikos M., Meyer K.A., Sedmak G., Guennel T., Shin Y., Johnson M.B., Krsnik Z., Mayer S., Fertuzinhos S., Umlauf S., Lisgo S.N., Vortmeyer A., Weinberger D.R., Mane S., Hyde T.M., Huttner A., Reimers M., Kleinman J.E., Sestan N. Spatio-temporal transcriptome of the human brain. Nature 2011, 478(7370):483-489.
30. Levin Y., Wang L., Schwarz E., Koethe D., Leweke F.M., Bahn S. Global proteomic profiling reveals altered proteomic signature in schizophrenia serum. Mol. Psychiatry 2010, 15(11):1088-1100.
31. Li X., Zhang W., Zhang C., Gong W., Tang J., Yi Z., Wang D., Lu W., Fang Y., Chen X., Yao Y.-G. No association between genetic variants of the LRRK2 gene and schizophrenia in Han Chinese. Neurosci. Lett. 2014, 566:210-215.
32. Liu J.Z., McRae A.F., Nyholt D.R., Medland S.E., Wray N.R., Brown K.M., Investigators A.M.F.S., Hayward N.K., Montgomery G.W., Visscher P.M., Martin N.G., Macgregor S. A versatile gene-based test for genome-wide association studies. Am. J. Hum. Genet. 2010, 87(1):139-145.
33. Ma L., Tang J., Wang D., Zhang W., Liu W., Wang D., Liu X.-H., Gong W., Yao Y.-G., Chen X. Evaluating risk loci for schizophrenia distilled from genome-wide association studies in Han Chinese from central China. Mol. Psychiatry 2013, 18(6):638-639.
34. Messeguer X., Escudero R., Farré D., Núñez O., Martínez J., Albà M.M. PROMO: detection of known transcription regulatory elements using species-tailored searches. Bioinformatics 2002, 18(2):333-334.
35. Rapoport J.L., Giedd J.N., Gogtay N. Neurodevelopmental model of schizophrenia: update 2012. Mol. Psychiatry 2012, 17(12):1228-1238.
36. Ripke S., O'Dushlaine C., Chambert K., Moran J.L., Kähler A.K., Akterin S., Bergen S.E., Collins A.L., Crowley J.J., Fromer M., Kim Y., Lee S.H., Magnusson P.K., Sanchez N., Stahl E.A., Williams S., Wray N.R., Xia K., Bettella F., Borglum A.D., Bulik-Sullivan B.K., Cormican P., Craddock N., de Leeuw C., Durmishi N., Gill M., Golimbet V., Hamshere M.L., Holmans P., Hougaard D.M., Kendler K.S., Lin K., Morris D.W., Mors O., Mortensen P.B., Neale B.M., O'Neill F.A., Owen M.J., Milovancevic M.P., Posthuma D., Powell J., Richards A.L., Riley B.P., Ruderfer D., Rujescu D., Sigurdsson E., Silagadze T., Smit A.B., Stefansson H., Steinberg S., Suvisaari J., Tosato S., Verhage M., Walters J.T., Multicenter Genetic Studies of Schizophrenia Consortium, Levinson D.F., Gejman P.V., Kendler K.S., Laurent C., Mowry B.J., O'Donovan M.C., Owen M.J., Pulver A.E., Riley B.P., Schwab S.G., Wildenauer D.B., Dudbridge F., Holmans P., Shi J., Albus M., Alexander M., Campion D., Cohen D., Dikeos D., Duan J., Eichhammer P., Godard S., Hansen M., Lerer F.B., Liang K.Y., Maier W., Mallet J., Nertney D.A., Nestadt G., Norton N., O'Neill F.A., Papadimitriou G.N., Ribble R., Sanders A.R., Silverman J.M., Walsh D., Williams N.M., Wormley B., Psychosis Endophenotypes International Consortium, Arranz M.J., Bakker S., Bender S., Bramon E., Collier D., Crespo-Facorro B., Hall J., Iyegbe C., Jablensky A., Kahn R.S., Kalaydjieva L., Lawrie S., Lewis C.M., Lin K., Linszen D.H., Mata I., McIntosh A., Murray R.M., Ophoff R.A., Powell J., Rujescu D., Van Os J., Walshe M., Weisbrod M., Wiersma D., Wellcome Trust Case Control Consortium 2, Donnelly P., Barroso I., Blackwell J.M., Bramon E., Brown M.A., Casas J.P., Corvin A.P., Deloukas P., Duncanson A., Jankowski J., Markus H.S., Mathew C.G., Palmer C.N., Plomin R., Rautanen A., Sawcer S.J., Trembath R.C., Viswanathan A.C., Wood N.W., Spencer C.C., Band G., Bellenguez C., Freeman C., Hellenthal G., Giannoulatou E., Pirinen M., Pearson R.D., Strange A., Su Z., Vukcevic D., Donnelly P., Langford C., Hunt S.E., Edkins S., Gwilliam R., Blackburn H., Bumpstead S.J., Dronov S., Gillman M., Gray E., Hammond N., Jayakumar A., McCann O.T., Liddle J., Potter S.C., Ravindrarajah R., Ricketts M., Tashakkori-Ghanbaria A., Waller M.J., Weston P., Widaa S., Whittaker P., Barroso I., Deloukas P., Mathew C.G., Blackwell J.M., Brown M.A., Corvin A.P., McCarthy M.I., Spencer C.C., Bramon E., Corvin A.P., O'Donovan M.C., Stefansson K., Scolnick E., Purcell S., McCarroll S.A., Sklar P., Hultman C.M., Sullivan P.F. Genome-wide association analysis identifies 13 new risk loci for schizophrenia. Nat. Genet. 2013, 45(10):1150-1159.
37. Schmid R.S., Graff R.D., Schaller M.D., Chen S., Schachner M., Hemperly J.J., Maness P.F. NCAM stimulates the Ras-MAPK pathway and CREB phosphorylation in neuronal cells. J. Neurobiol. 1999, 38(4):542-558.
38. Schmitt A., Hasan A., Gruber O., Falkai P. Schizophrenia as a disorder of disconnectivity. Eur. Arch. Psychiatry Clin. Neurosci. 2011, 261(Suppl. 2):S150-S154.
39. Schwarz E., Guest P.C., Rahmoune H., Harris L.W., Wang L., Leweke F.M., Rothermundt M., Bogerts B., Koethe D., Kranaster L., Ohrmann P., Suslow T., McAllister G., Spain M., Barnes A., van Beveren N.J., Baron-Cohen S., Steiner J., Torrey F.E., Yolken R.H., Bahn S. Identification of a biological signature for schizophrenia in serum. Mol. Psychiatry 2012, 17(5):494-502.
40. Stephens M., Smith N.J., Donnelly P. A new statistical method for haplotype reconstruction from population data. Am. J. Hum. Genet. 2001, 68(4):978-989.
41. Sullivan P.F., Kendler K.S., Neale M.C. Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. Arch. Gen. Psychiatry 2003, 60(12):1187-1192.
42. Sullivan P.F., Keefe R.S., Lange L.A., Lange E.M., Stroup T.S., Lieberman J., Maness P.F. NCAM1 and neurocognition in schizophrenia. Biol. Psychiatry 2007, 61(7):902-910.
43. The 1000 Genomes Project Consortium An integrated map of genetic variation from 1,092 human genomes. Nature 2012, 491(7422):56-65.
44. Vawter M.P. Dysregulation of the neural cell adhesion molecule and neuropsychiatric disorders. Eur. J. Pharmacol. 2000, 405(1-3):385-395.
45. Vicente A.M., Macciardi F., Verga M., Bassett A.S., Honer W.G., Bean G., Kennedy J.L. NCAM and schizophrenia: genetic studies. Mol. Psychiatry 1997, 2(1):65-69.
46. Wang D., Feng J.-Q., Li Y.-Y., Zhang D.-F., Li X.-A., Li Q.-W., Yao Y.-G. Genetic variants of the MRC1 gene and the IFNG gene are associated with leprosy in Han Chinese from Southwest China. Hum. Genet. 2012, 131(7):1251-1260.
47. Weinhold B., Seidenfaden R., Röckle I., Mühlenhoff M., Schertzinger F., Conzelmann S., Marth J.D., Gerardy-Schahn R., Hildebrandt H. Genetic ablation of polysialic acid causes severe neurodevelopmental defects rescued by deletion of the neural cell adhesion molecule. J. Biol. Chem. 2005, 280(52):42971-42977.
48. Xiao M.-S., Zhang D.-F., Zeng Y., Cheng Y.-F., Yao Y.-G. Polymorphisms in the promoter region of the CASP8 gene are not associated with non-Hodgkin's lymphoma in Chinese patients. Ann. Hematol. 2011, 90(10):1137-1144.
49. Xu Z., He Z., Huang K., Tang W., Li Z., Tang R., Xu Y., Feng G., He L., Shi Y. No genetic association between NCAM1 gene polymorphisms and schizophrenia in the Chinese population. Prog. Neuropsychopharmacol. Biol. Psychiatry 2008, 32(7):1633-1636.
50. Yang J., Chen T., Sun L., Zhao Z., Qi X., Zhou K., Cao Y., Wang X., Qiu Y., Su M., Zhao A., Wang P., Yang P., Wu J., Feng G., He L., Jia W., Wan C. Potential metabolite markers of schizophrenia. Mol. Psychiatry 2013, 18(1):67-78.
51. Zhang W., Tang J., Zhang A.-M., Peng M.-S., Xie H.-B., Tan L., Xu L., Zhang Y.-P., Chen X., Yao Y.-G. A matrilineal genetic legacy from the Last Glacial Maximum confers susceptibility to schizophrenia in Han Chinese. J. Genet. Genomics 2014, 41(7):397-407.
52. Zhao Y., Ji S., Wang J., Huang J., Zheng P. mRNA-Seq and microRNA-Seq whole-transcriptome analyses of rhesus monkey embryonic stem cell neural differentiation revealed the potential regulators of rosette neural stem cells. DNA Res. 2014, (in press). 10.1093/dnares/dsu019.